Overdosed paracetamol (acetaminophen) prescriptions and subsequent pharmacist interventions in French hospitals

MARTINDALE – The Complete Drug Reference. Online version. http://www.thomsonhc.com/hcs/librarian. Last consultation: December 8th, 2012. Agence nationale de sécurité du médicament et des produits de santé. Fiche d’aide à la dispensation du paracétamol (01/07/2008) http://ansm.sante.fr/var/ansm_site/storage/original/application/b160fb16140cb64440f685bd82ceb6ad.pdf. 2 pages, last consultation January 10, 2013. Agence nationale de sécurité du médicament et des produits de santé. Informations importantes de pharmacovigilance concernant le PARACETAMOL PANPHARMA® 10mg/mL, solution pour perfusion 30/10/2008 : http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Informations-importantes-de-pharmacovigilance-concernant-le-PARACETAMOL-PANPHARMA-R-10-mg-ml-solution-pour-perfusion/(language)/fre-FR. 3 pages, last consultation January 10, 2013. Albertson, 2010, A population study of the frequency of high-dose acetaminophen prescribing and dispensing, Ann Pharmacother, 44, 1191, 10.1345/aph.1P012 Gokhale, 2012, Prescription-acquired acetaminophen use and potential overuse patterns: 2001–2008, Pharmacoepidemiol Drug Saf, 21, 226, 10.1002/pds.2235 Mort, 2011, Opioid-paracetamol prescription patterns and liver dysfunction: a retrospective cohort study in a population served by a US health benefits organization, Drug Saf, 34, 1079, 10.2165/11593100-000000000-00000 Arques-Armoiry, 2010, [Most frequent drug-related events detected by pharmacists during prescription analysis in a university hospital], Rev Med Interne, 31, 804, 10.1016/j.revmed.2010.08.001 Claridge, 2010, Acute liver failure after administration of paracetamol at the maximum recommended daily dose in adults, BMJ, 341, c6764, 10.1136/bmj.c6764 Charpiat, 2012, Overdosed prescription of paracetamol (acetaminophen) in a teaching hospital, Ann Pharm Fr, 70, 213, 10.1016/j.pharma.2012.05.002 Zhou, 2012, Supratherapeutic dosing of acetaminophen among hospitalized patients, Arch Intern Med, 172, 1721, 10.1001/2013.jamainternmed.438 Hawkey, 1990, Effect of reactive pharmacy intervention on quality of hospital prescribing, BMJ, 300, 986, 10.1136/bmj.300.6730.986 Kaboli, 2006, Clinical pharmacists and inpatient medical care: a systematic review, Arch Intern Med, 166, 955, 10.1001/archinte.166.9.955 Simonian, 2003, Documenting pharmacist interventions on an intranet, Am J Health Syst Pharm, 60, 151, 10.1093/ajhp/60.2.151 Kim, 2003, Pharmacist intervention documentation in US health care systems, Hosp Pharm, 38, 1141, 10.1177/001857870303801211 McLennan, 2000, Multicentre pilot study of a standard approach to document clinical pharmacy activity, Aust J Hosp Pharm, 30, 150, 10.1002/jppr2000304150 Allenet, 2006, Validation of an instrument for the documentation of clinical pharmacists’ interventions, Pharm World Sci, 28, 181, 10.1007/s11096-006-9027-5 Bedouch, 2007, [The French Society of Clinical Pharmacy website for the documentation and analysis of pharmacist's interventions: purpose, instructions and perspectives], J Pharm Clin, 26, 40 Bedouch, 2008, Assessment of clinical pharmacists’ interventions in French hospitals: results of a multicenter study, Ann Pharmacother, 42, 1095, 10.1345/aph.1L045 Haute Autorité de santé. Indicateurs de qualité généralisés en MCO Campagne 2011 Analyse descriptive des résultats agrégés et analyse des facteurs associés à la variabilité des résultats. Juin 2012. [Available at: http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-07/ipaqss_rapport_mco_v4.pdf. Last consultation February 3, 2013]. Haute Autorité de santé. Indicateurs de qualité généralisés en SSR. Campagne 2011. Analyse descriptive des résultats agrégés et analyse des facteurs associés à la variabilité des résultats. Septembre 2012. [Available at: http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-10/ipaqss-rapport-ssr-v4.pdf. Last consultation February 3, 2013]. van Grootheest, 2002, Labelling and ‘Dear Doctor’ letters: are they noncommittal?, Drug Saf, 25, 1051, 10.2165/00002018-200225150-00001 Théophile, 2011, Relevance of a “Dear Doctor letter” to alert healthcare providers to new recommendations for vitamin D administration, Eur J Clin Pharmacol, 67, 681, 10.1007/s00228-011-1055-y Hornsby, 2010, Survey of physician knowledge and counseling practices regarding acetaminophen, J Patient Saf, 6, 216, 10.1097/PTS.0b013e3181fca8b4 Leung, 2012, Impact of vendor computerized physician order entry in community hospitals, J Gen Intern Med, 27, 801, 10.1007/s11606-012-1987-7 Johnson, 2005, Modeling sources of self-report bias in a survey of drug use epidemiology, Ann Epidemiol, 15, 381, 10.1016/j.annepidem.2004.09.004 Thompson, 2005, Reliability among senior managers of the Marlowe-Crowne short-form social desirability scale, J Business Psychol, 19, 541, 10.1007/s10869-005-4524-4 Food and Drug Administration. Acetaminophen and Liver Injury: Q & A for Consumers. Available at: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm168830.htm. (Last consultation September 9th, 2012). Australian Government. Department of Health an Ageing. Guidelines released for safe use of paracetamol, 2 June 2003. http://www.health.gov.au/internet/main/publishing.nsf/Content/health-mediarel-yr2003-tw-tw03025.htm. (Last consultation September 9th, 2012). Safekids Campaign 06/07. Paracetamol Poisoning Prevention Project Plan. June 2006. http://www.safekids.org.nz/Downloads/Safekids%20Resources/Poisoning/Safekids%20Paracetamol%20Poison%20Prevention%20Project%20Plan%202006.pdf. (Last consultation September 9th, 2012). Lubel, 2007, Accidental paracetamol poisoning, Med J Aust, 186, 371, 10.5694/j.1326-5377.2007.tb00943.x Forget, 2009, Therapeutic dose of acetaminophen may induce fulminant hepatitis in the presence of risk factors: a report of two cases, Br J Anaesth, 103, 899, 10.1093/bja/aep322